Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Kathleen M. Dungan MD, MPH Advisory Board

Deborah J. Wexler MD, MSc Associate Editor

Richard E. Pratley MD Associate Editor

See All Experts

story of the week

Published in Diabetes and

Journal Scan / Research · October 06, 2020

SGLT2 Inhibitors May Lower Risk of Major Adverse Cardiovascular Events

BMJ: British Medical Journal

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Peter Lin MD, CCFP

BMJ: British Medical Journal

Sodium Glucose Cotransporter 2 Inhibitors and Risk of Major Adverse Cardiovascular Events: Multi-Database Retrospective Cohort Study

BMJ 2020 Sep 23;370(xx)m3342, KB Filion, LM Lix, OH Yu, S Dell'Aniello, A Douros, BR Shah, A St-Jean, A Fisher, E Tremblay, SC Bugden, S Alessi-Severini, PE Ronksley, N Hu, CR Dormuth, P Ernst, S Suissa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

SGLT2 Inhibitors May Lower Risk of Major Adverse Cardiovascular Events

Additional Info

Sodium Glucose Cotransporter 2 Inhibitors and Risk of Major Adverse Cardiovascular Events: Multi-Database Retrospective Cohort Study

Further Reading

Real-World Effectiveness of Oral Semaglutide in Adults and Older Individuals With Type 2 Diabetes

Effect of Combined Use of SGLT2 Inhibitors and Pioglitazone on the Risk of MASH in Individuals With Type 2 Diabetes

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Implications of Continuous Ketone Monitoring in Clinical Practice

Characterizing the Effects of Using GLP-1 Receptor–Based Agonists on Body Composition

The SEAD Program Improved Clinical Outcomes in Underserved Young Adults With Type 1 Diabetes

Predicting Hypoglycemia and Hyperglycemia Risks During and After Physical Activity in Adolescents With Type 1 Diabetes

Family History of Diabetes and Clinical Characteristics in Children at the Diagnosis of Type 1 Diabetes

Effect of Sarcopenic Obesity on the Progression of Glycaemic Status in Middle-Aged and Older Adults Without Diabetes

Association of Early Post-Transplantation Hyperglycaemia and Diabetes Mellitus on Outcomes Following Heart Transplantation

Associations of Diabetes and Prediabetes With Mortality and Life Expectancy in Chinese Individuals

Recently Updated